Immunogen Inc. buy Piper Sandler
Start price
03.05.23
/
50%
€10.66
Target price
03.05.24
€14.47
Performance (%)
171.76%
End price
04.05.24
-
Summary
This prediction is currently being closed. With a performance of 171.76% the BUY prediction by Piper_Sandler is a big success. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Immunogen Inc. | - | - | - |
iShares Core DAX® | 0.039% | 0.567% | 12.281% |
iShares Nasdaq 100 | -4.018% | -5.554% | 23.851% |
iShares Nikkei 225® | -2.389% | -1.434% | 8.335% |
iShares S&P 500 | -2.115% | -2.351% | 22.061% |
Comments by Piper_Sandler for this prediction
In the thread Immunogen Inc. diskutieren
ImmunoGen, Inc. (NASDAQ: IMGN) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $6.00.
Ratings data for IMGN provided by MarketBeat
In the thread Trading Immunogen Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten